Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gene Logic finds Parkinson's markers:

This article was originally published in Clinica

Executive Summary

A collaboration involving US firm Gene Logic has identified biomarkers that predict susceptibility to Parkinson's disease and age of disease onset, the Gaithersburg, Maryland company has reported. In a study, conducted with the Mayo Clinic in the US, the company provided gene expression data analysis and data interpretation, comparing the whole-genome study data with the company's Parkinson's disease gene expression knowledge-base. The firm believes that the study augments its intellectual property position around a growing set of useful markers for Parkinson's disease and other complex diseases, affording "excellent" opportunities to develop diagnostic, prognostic or therapeutic products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048961

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel